To evaluate the safety and efficacy of fruquintinib combined with standard chemotherapy in the second-line treatment of advanced colorectal cancer after failure of first-line standard bevacizumab: a single-arm, prospective, exploratory clinical study
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/86284
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Experimental group :fruquintinib combined with standard chemotherapy
Primary outcome(s): Progression free survival
Study Design: Single arm
创建时间：
2023-04-15
